Skip to main content

Use of patient-reported global assessment measures in clinical trials of chronic pain treatments: ACTTION systematic review and considerations.

Publication ,  Journal Article
Langford, DJ; Mark, RP; France, FO; Nishtar, M; Park, M; Sharma, S; Shklyar, IC; Schnitzer, TJ; Conaghan, PG; Amtmann, D; Reeve, BB; Turk, DC ...
Published in: Pain
November 1, 2024

Establishing clinically meaningful changes in pain experiences remains important for clinical trials of chronic pain treatments. Regulatory guidance and pain measurement initiatives have recommended including patient-reported global assessment measures (eg, Patient-Global Impression of Change [PGIC]) to aid interpretation of within-patient differences in domain-specific clinical trial outcomes (eg, pain intensity). The objectives of this systematic review were to determine the frequency of global assessment measures inclusion, types of measures, domains assessed, number and types of response options, and how measures were analyzed. Of 4172 abstracts screened across 6 pain specialty journals, we reviewed 96 clinical trials of chronic pain treatments. Fifty-two (54.2%) studies included a global assessment measure. The PGIC was most common (n = 28; 53.8%), with relatively infrequent use of other measures. The majority of studies that used a global assessment measure (n = 31; 59.6%) assessed change or improvement in an unspecified domain. Others assessed overall condition severity (n = 9; 17.3%), satisfaction (n = 8; 15.4%), or overall health status/recovery (n = 5; 9.6%). The number, range, and type of response options were variable and frequently not reported. Response options and reference periods even differed within the PGIC. Global assessment measures were most commonly analyzed as continuous variables (n = 24; 46.2%) or as dichotomous variables with positive categories combined to calculate the proportion of participants with a positive response to treatment (n = 18; 34.6%). This review highlights the substantial work necessary to clarify measurement and use of patient global assessment in chronic pain trials and provides short- and long-term considerations for measure selection, reporting and analysis, and measure development.

Duke Scholars

Published In

Pain

DOI

EISSN

1872-6623

Publication Date

November 1, 2024

Volume

165

Issue

11

Start / End Page

2445 / 2454

Location

United States

Related Subject Headings

  • Patient Reported Outcome Measures
  • Pain Measurement
  • Pain Management
  • Humans
  • Clinical Trials as Topic
  • Chronic Pain
  • Anesthesiology
  • 52 Psychology
  • 42 Health sciences
  • 32 Biomedical and clinical sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Langford, D. J., Mark, R. P., France, F. O., Nishtar, M., Park, M., Sharma, S., … Gewandter, J. S. (2024). Use of patient-reported global assessment measures in clinical trials of chronic pain treatments: ACTTION systematic review and considerations. Pain, 165(11), 2445–2454. https://doi.org/10.1097/j.pain.0000000000003270
Langford, Dale J., Remington P. Mark, Fallon O. France, Mahd Nishtar, Meghan Park, Sonia Sharma, Isabel C. Shklyar, et al. “Use of patient-reported global assessment measures in clinical trials of chronic pain treatments: ACTTION systematic review and considerations.Pain 165, no. 11 (November 1, 2024): 2445–54. https://doi.org/10.1097/j.pain.0000000000003270.
Langford DJ, Mark RP, France FO, Nishtar M, Park M, Sharma S, et al. Use of patient-reported global assessment measures in clinical trials of chronic pain treatments: ACTTION systematic review and considerations. Pain. 2024 Nov 1;165(11):2445–54.
Langford, Dale J., et al. “Use of patient-reported global assessment measures in clinical trials of chronic pain treatments: ACTTION systematic review and considerations.Pain, vol. 165, no. 11, Nov. 2024, pp. 2445–54. Pubmed, doi:10.1097/j.pain.0000000000003270.
Langford DJ, Mark RP, France FO, Nishtar M, Park M, Sharma S, Shklyar IC, Schnitzer TJ, Conaghan PG, Amtmann D, Reeve BB, Turk DC, Dworkin RH, Gewandter JS. Use of patient-reported global assessment measures in clinical trials of chronic pain treatments: ACTTION systematic review and considerations. Pain. 2024 Nov 1;165(11):2445–2454.

Published In

Pain

DOI

EISSN

1872-6623

Publication Date

November 1, 2024

Volume

165

Issue

11

Start / End Page

2445 / 2454

Location

United States

Related Subject Headings

  • Patient Reported Outcome Measures
  • Pain Measurement
  • Pain Management
  • Humans
  • Clinical Trials as Topic
  • Chronic Pain
  • Anesthesiology
  • 52 Psychology
  • 42 Health sciences
  • 32 Biomedical and clinical sciences